THQ · NYSE · Closed-end fund
abrdn Healthcare Opportunities Fund (THQ) Price, Holdings & Fees
abrdn Healthcare Opportunities Fund (THQ) closed at $788.14 on Oct 9, 2026, up 0.58% from the previous close of $783.58.
Share price, past year
1Y +52.67%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $788.14 |
| Sep 30, 2026 | $767.59 |
| Aug 31, 2026 | $696.87 |
| Jul 31, 2026 | $675.98 |
| Jun 30, 2026 | $709.46 |
| May 29, 2026 | $702.79 |
| Apr 30, 2026 | $684.96 |
| Mar 31, 2026 | $675.00 |
| Feb 27, 2026 | $636.96 |
| Jan 30, 2026 | $612.42 |
| Dec 31, 2025 | $544.81 |
| Nov 28, 2025 | $539.02 |
| Oct 31, 2025 | $538.31 |
Key statistics
- Expense ratio
- —
- Net assets
- $825.7M
- as of Jun 30, 2026
- Holdings
- 110
- as of Jun 30, 2026
- 52-week range
- $506.69 – $788.14
Holdings
abrdn Healthcare Opportunities Fund held 110 investments worth $825.73M as of Jun 30, 2026. Its largest holding was UnitedHealth Group Inc, at 6.07% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | UnitedHealth Group Inc | 6.07% | $50.14M |
| 2 | VeraDermics Inc | 5.27% | $43.49M |
| 3 | Abbott Laboratories | 4.77% | $39.35M |
| 4 | Merck & Co Inc | 4.41% | $36.39M |
| 5 | Medtronic PLC | 4.26% | $35.20M |
| 6 | Thermo Fisher Scientific Inc | 4.19% | $34.57M |
| 7 | VERADERMICS, INC. | 4.07% | $33.59M |
| 8 | Intuitive Surgical Inc | 3.39% | $28.00M |
| 9 | CVS Health Corp | 3.30% | $27.26M |
| 10 | Danaher Corp | 3.22% | $26.62M |
| 11 | Oruka Therapeutics Inc | 2.89% | $23.87M |
| 12 | uniQure NV | 2.77% | $22.89M |
| 13 | Humana Inc | 2.75% | $22.72M |
| 14 | Elevance Health Inc | 2.56% | $21.13M |
| 15 | BioCryst Pharmaceuticals Inc | 2.53% | $20.89M |
| 16 | AbbVie Inc | 2.47% | $20.36M |
| 17 | Boston Scientific Corp | 2.40% | $19.85M |
| 18 | Sarepta Therapeutics Inc | 2.01% | $16.56M |
| 19 | NeoGenomics Inc | 1.89% | $15.61M |
| 20 | Insulet Corp | 1.88% | $15.48M |
| 21 | State Street Global Advisors | 1.86% | $15.34M |
| 22 | Praxis Precision Medicines Inc | 1.77% | $14.65M |
| 23 | ARS Pharmaceuticals Inc | 1.75% | $14.46M |
| 24 | Abivax SA | 1.68% | $13.90M |
| 25 | Alignment Healthcare Inc | 1.66% | $13.74M |
Top 25 of 110 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 106.00% |
| Bonds and other debt | 12.00% |
| Preferred stock | 7.52% |
| Cash and short-term investments | 1.86% |
| Derivatives | −0.02% |
| Country | % of fund |
|---|---|
| United States | 114.82% |
| Ireland | 5.65% |
| Netherlands | 2.77% |
| France | 1.68% |
| Switzerland | 1.16% |
| United Kingdom | 0.64% |
| Cayman Islands | 0.47% |
| Luxembourg | 0.17% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, abrdn Healthcare Opportunities Fund's total return was +14.82%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +1.28% |
| May 31, 2026 | +1.06% |
| Apr 30, 2026 | +12.18% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- abrdn Healthcare Opportunities Fund
- Ticker
- THQ
- Exchange
- NYSE
- Fund type
- Closed-end fund
- SEC CIK
- 0001604522
- Fractional shares
- Yes
Recent SEC filings
- Aug 28, 2026
- Jun 8, 2026
- Dec 8, 2025
- Jun 9, 2025
- Dec 9, 2024
- Jun 10, 2024
- Dec 11, 2023
- Sep 12, 2023
Frequently asked questions
What is THQ's price?
abrdn Healthcare Opportunities Fund (THQ) closed at $788.14 on Oct 9, 2026, up 0.58% from the previous close of $783.58.
What does THQ hold?
abrdn Healthcare Opportunities Fund held 110 investments worth $825.73M as of Jun 30, 2026. Its largest holding was UnitedHealth Group Inc, at 6.07% of the fund. Its five largest holdings were UnitedHealth Group Inc, VeraDermics Inc, Abbott Laboratories, Merck & Co Inc, Medtronic PLC.
How has THQ performed?
Over the 3 months to Jun 30, 2026, abrdn Healthcare Opportunities Fund's total return was +14.82%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 28, 2026). Prices are generated sample data for development. Data sources and disclosures